Is Former CStone Chairman the Medicine Ailing Hengrui Needs?
Hengrui Medicine started the New Year by naming CStone’s previous top official Jiang Ningjun as its new vice general manager and chief strategy officer.Key Takeaways:Hengrui Pharma has named the former…
Recent Articles
RELATED ARTICLES
-
CSPC Pharma taps R&D superstar in quest for new breakout drugs
1093.HK
-
Stock disconnect triggers investor exodus from CStone Pharma
2616.HK
-
Novel drugs lift Sino Biopharm earnings, easing price-cap pain
1177.HK
-
Facing revenue crisis, Ascletis Pharma tries to bulk up with obesity drugs
1672.HK
-
Innovent Bio hopes for plus-sized profits from obesity drug
1801.HK
Discover hidden China stock gems in our weekly newsletter